Do the clonally different <i>Escherichia coli</i> isolates causing different infections in a HIV positive patient affect the selection of antibiotics for their treatment?

Rameshkumar, Marimuthu Ragavan; Arunagirinathan, Narasingam; Swathirajan, Chinnambedu Ravichandran; Vignesh, Ramachandran; Balakrishnan, Pachamuthu; Solomon, Sunil Suhas

Do the clonally different Escherichia coli isolates causing different infections in a HIV positive patient affect the selection of antibiotics for their treatment?

Rameshkumar, Marimuthu Ragavan; Arunagirinathan, Narasingam; Swathirajan, Chinnambedu Ravichandran; Vignesh, Ramachandran; Balakrishnan, Pachamuthu; Solomon, Sunil Suhas.

Afiliação

Rameshkumar MR; Department of Microbiology and Biotechnology, Presidency College (Autonomous); Infectious Diseases Laboratory, YRG Centre for AIDS Research and Education, Voluntary Health Services Hospital Campus, Chennai, India.
Arunagirinathan N; Department of Microbiology and Biotechnology, Presidency College (Autonomous); Faculty of Allied Health Sciences, Meenakshi Academy of Higher Education and Research (Deemed to be University), Chennai, India.
Swathirajan CR; Infectious Diseases Laboratory, YRG Centre for AIDS Research and Education, Voluntary Health Services Hospital Campus, Chennai, India.
Vignesh R; Infectious Diseases Laboratory, YRG Centre for AIDS Research and Education, Voluntary Health Services Hospital Campus, Chennai, India; Preclinical Department, Faculty of Medicine, Universiti Kuala Lumpur Royal College of Medicine Perak, Ipoh, Malaysia.
Balakrishnan P; Infectious Diseases Laboratory, YRG Centre for AIDS Research and Education, Voluntary Health Services Hospital Campus, Chennai, India.
Solomon SS; Infectious Diseases Laboratory, YRG Centre for AIDS Research and Education, Voluntary Health Services Hospital Campus, Chennai, India; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA.

Indian J Med Res ; 148(3): 341-344, 2018 09.

Article em En | MEDLINE | ID: mdl-30425226

Assuntos

Antibacterianos; Infecções por Escherichia coli; Escherichia coli; Soropositividade para HIV; Adulto; Antibacterianos/classificação; Antibacterianos/uso terapêutico; Farmacorresistência Bacteriana/efeitos dos fármacos; Farmacorresistência Bacteriana/genética; Escherichia coli/efeitos dos fármacos; Escherichia coli/genética; Escherichia coli/isolamento & purificação; Infecções por Escherichia coli/complicações; Infecções por Escherichia coli/tratamento farmacológico; Infecções por Escherichia coli/epidemiologia; Infecções por Escherichia coli/microbiologia; Soropositividade para HIV/complicações; Soropositividade para HIV/diagnóstico; Soropositividade para HIV/epidemiologia; Humanos; Índia/epidemiologia; Masculino; Testes de Sensibilidade Microbiana/métodos; Seleção de Pacientes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Soropositividade para HIV / Escherichia coli / Infecções por Escherichia coli / Antibacterianos Tipo de estudo: Diagnostic_studies Limite: Adult / Humans / Male País como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google